Concepedia

Yu-Hsi Lin

YL

19

Publications

3.9K

Citations

15

H-Index

2002

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Harvard University

Beth Israel Deaconess Medical Center

The University of Texas Health Science Center at Houston

Henry Ford Hospital

Yu-Hsi Lin is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cell biology, and tumor biology.

Top concepts

MedicineCell BiologyTumor BiologyCancer ResearchPharmacologyTumor MicroenvironmentGliomaImmunologyCancer BiologyNeuro-oncology

Publications per year

2002–2022

19

Publications

19

Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment

Qianghu Wang, Baoli Hu, Xin Hu et al. · Cancer Cell · 2017 · 2K citations · Full text

Neuro-oncology, Glioma, Tumor Heterogeneity +10

An inhibitor of oxidative phosphorylation exploits cancer vulnerability

Jennifer R. Molina, Yuting Sun, Marina Protopopova et al. · Nature Medicine · 2018 · 903 citations · Full text

Medicine, Anti-cancer Agent, Cancer Vulnerability +4

Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer

Yonathan Lissanu Deribe, Yuting Sun, Christopher Terranova et al. · Nature Medicine · 2018 · 263 citations · Full text

Oncogenic Agent, Medicine, Targetable Dependence +7

KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung Cancer

Hunain Alam, Ming Tang, Mayinuer Maitituoheti et al. · Cancer Cell · 2020 · 233 citations · Full text

Oncogenic Agent, Medicine, Cancer Cell Biology +8

SF2312 is a natural phosphonate inhibitor of enolase

Paul G. Leonard, Nikunj Satani, David S. Maxwell et al. · Nature Chemical Biology · 2016 · 97 citations · Full text

Medicine, Mechanism Of Action, Natural Phosphonate Inhibitor +5

Rows per page

1–5 of 19